Inogen (INGN) Accumulated Expenses (2013 - 2026)

Inogen (INGN) has reported Accumulated Expenses for 14 consecutive years, with $10.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Accumulated Expenses rose 156.02% year-over-year to $10.2 million; the TTM figure through Mar 2026 stood at $10.2 million (up 156.02% YoY), while the FY2025 annual figure was $3.9 million, down 38.79% from the prior year.
• Accumulated Expenses climbed to $10.2 million in Q1 2026 per INGN's latest filing, from $3.9 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $14.3 million in Q3 2024 and bottomed at $1.1 million in Q4 2023.
• Historically, Accumulated Expenses has averaged $6.3 million across 5 years, with a median of $4.1 million in 2025.
• Annual changes were most pronounced in 2022 — Accumulated Expenses surged 658.06% — and 2025, when it tumbled 70.1%.
• Inogen's Accumulated Expenses stood at $2.6 million in 2022, then tumbled by 57.63% to $1.1 million in 2023, then jumped by 473.87% to $6.4 million in 2024, then slumped by 38.79% to $3.9 million in 2025, then jumped by 161.4% to $10.2 million in 2026.
• Business Quant data shows INGN's Accumulated Expenses at $10.2 million in Q1 2026, $3.9 million in Q4 2025, and $4.3 million in Q3 2025.